<DOC>
	<DOCNO>NCT00000797</DOCNO>
	<brief_summary>The Women 's Interagency HIV Study ( WIHS ) , multicenter , prospective study , establish August 1993 carry comprehensive investigation impact HIV infection clinical , laboratory , psychosocial effect woman . The purpose study collect evaluate data HIV infect at-risk woman well understand provide support woman currently HIV infect risk HIV infection .</brief_summary>
	<brief_title>Women 's Interagency HIV Study ( WIHS )</brief_title>
	<detailed_description>HIV woman increase worldwide , woman comprise approximately 14 % total adult adolescent AIDS case , high proportion yet report . The impact AIDS particularly severe minority population ; among woman , African Americans , Hispanics combine represent majority AIDS case ( 76 % ) United States . AIDS third lead cause death woman age 25 44 ( cancer cardiovascular disease ) lead cause death African American woman age group . Studies HIV AIDS woman play unique role test new biological socio-behavioral hypothesis population level link basic science finding laboratory method well-defined population community . Research area likely draw attention near future include study pathogenicity transmissibility different HIV subtypes recombinant form interaction variably susceptible individual ; change scope HIV natural history study era combination antiretroviral therapy ; contribution study design wide spectrum prevention modality ( e.g. , prevention HIV prevention opportunistic infection ) . In addition , study natural history HIV-related malignancy active surveillance malignancy HIV infect high-risk uninfected woman may lead new screen prevention modality high-risk population woman . Participants study visit every 6 month . Questionnaires regard sexual behavior , health care utilization , medical obstetric/gynecological history , psychosocial factor , sociodemographics complete participant . Physical , gynecological , lipodystrophy examination also conduct visit , current medication regimen note . Blood bodily fluid sample collect register local national repository WIHS conjunction NIAID .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>HIV infection Willing retested HIV infection study unless hardcopy documentation positive result ( HIV ELISA test confirmatory Western blot ) available Either never take HIV antiretroviral medication document start date highly active antiretroviral therapy ( HAART ) January 1 , 2008 If take HAART , documentation preHAART CD4 count HIV RNA quantification Willing able blood drawn Give consent specimen store WIHS national repository Able complete study visit interview English Spanish every 6 month Able travel site clinic participate study visit outpatient Perinatally acquire HIV Enrolled WIHS another site HAART start January 1 , 2008 , except pregnancy Participant plan move area within 12 month</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>